These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6129145)

  • 1. Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
    Cohen SL; Knight M; Tamminga CA; Chase TN
    Eur J Pharmacol; 1982 Sep; 83(3-4):213-22. PubMed ID: 6129145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to the anti-avoidance properties of cholecystokinin-octapeptide.
    Cohen SL; Knight M; Tamminga CA; Chase TN
    Peptides; 1983; 4(1):67-70. PubMed ID: 6306617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholecystokinin octapeptide sulphate ester and unsulphated cholecystokinin octapeptide on active avoidance behaviour in rats.
    Fekete M; Bokor M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(1-2):57-63. PubMed ID: 6306996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.
    Tieppo CA; Felicio LF; Nasello AG
    Peptides; 2001 Aug; 22(8):1291-8. PubMed ID: 11457523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of apomorphine-induced stereotyped behavior by cholecystokinin.
    Tieppo CA; Nasello AG; Felicio LF
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):683-95. PubMed ID: 9194149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of yohimbine on dopamine dependent behaviours in rats and mice.
    Bende MM; Bapat TR; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1990 Jul; 34(3):195-200. PubMed ID: 2286423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central activity of 2-amino-4-phosphonobutyric acid (AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1995; 47(1):9-17. PubMed ID: 7550555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
    Hoły Z; Wiśniewski K
    Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.
    Balsara JJ; Nandal NV; Burte NP; Jadhav JH; Chandorkar AG
    Psychopharmacology (Berl); 1984; 82(3):237-40. PubMed ID: 6425907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
    Wambebe C
    Jpn J Pharmacol; 1987 Feb; 43(2):121-8. PubMed ID: 2883335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFFECTS OF VERAPAMIL ON DOPAMINE DEPENDENT BEHAVIOURS IN RATS.
    Malekar AR; Balsara JJ; Gaonkar RK
    Indian J Physiol Pharmacol; 1999 Jan; 43(1):44-52. PubMed ID: 27093735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic-like properties of cholecystokinin analogs: distinctive mechanisms underlying similar behavioral profiles depending on the route of administration.
    De Witte P; Gewiss M; Roques B; Vanderhaeghen JJ
    Peptides; 1988; 9(4):739-43. PubMed ID: 2906429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small doses of apomorphine induce catalepsy and antagonize methamphetamine stereotypy in rats.
    Balsara JJ; Bapat TR; Gada VP; Chandorkar AG
    Psychopharmacology (Berl); 1982; 78(2):192-4. PubMed ID: 6817377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P; Sarau H; McKenzie G
    Eur J Pharmacol; 1976 Sep; 39(1):117-26. PubMed ID: 986946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1996; 48(4):415-23. PubMed ID: 9112682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
    Nowak K; Welsch-Kunze S; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):385-91. PubMed ID: 3405313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative explanation for apparent satiating properties of peripherally administered bombesin and cholecystokinin in domestic fowls.
    Savory CJ
    Physiol Behav; 1987; 39(2):191-202. PubMed ID: 3575453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.